Il-Yang Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Il-Yang Pharmaceutical Co. Ltd.
iShares Core MSCI Emerging Markets ETF
183,777
0.97%
0
0.01%
09/05/2018
Vanguard Total International Stock Index Fund
173,339
0.91%
0
0%
07/31/2018
Government Pension Fund - Global (The)
159,235
0.84%
108,704
0%
12/31/2017
Mirae Asset TIGER China Consumer
141,833
0.75%
-14,046
1.86%
04/30/2018
Vanguard Developed Markets Index Fund
73,204
0.38%
0
0%
07/31/2018
Mirae Asset TIGER 200
49,492
0.26%
-2,071
0.05%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
48,569
0.26%
1,891
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
32,546
0.17%
32,546
0.01%
01/31/2018
Vanguard FTSE All World (ex-US) Small Cap
32,123
0.17%
0
0.01%
07/31/2018
Mirae Asset TIGER Health Care ETF
26,073
0.14%
5,411
0.53%
04/30/2018
| Address |
110 Hagal-ro
Yongin GY 17096
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.ilyang.co.kr |
| Updated |
07/08/2019 |
| Il-Yang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products are medicines including ethical and over-the counter drugs under the brand names of NolTec, Supect, and Wonbi-D. The company was founded on July 1, 1946 and is headquartered in Yongin, South Korea. |
